3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
3
Phase 3
2
Phase 2
2
Status
Terminated
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Small Cell Lung Carcinoma
2
Neoplasms
1
Neoplasm Metastasis
1
Interventions
Cisplatin
186
Carboplatin
181
Paclitaxel
177
Docetaxel
145
Cyclophosphamide
129
Dexamethasone
117
pembrolizumab
106
Doxorubicin
103
Bevacizumab
103
Gemcitabine
102
Rituximab
96
Prednisone
87
Fluorouracil
86
Pemetrexed
81
Radiotherapy
77
Vincristine
71
Etoposide
71
Capecitabine
69
Nivolumab
68
Trastuzumab
67
Leucovorin
64
Cytarabine
57
Methotrexate
52
Oxaliplatin
49
atezolizumab
48
Lenalidomide
43
Ipilimumab
40
Filgrastim
40
Bortezomib
39
Sorafenib
38
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Has results
×
rovalpituzumab tesirine
×
Clear all
NCT03033511
2021-07-29
MERU
AbbVie
Phase 3
Terminated
748 enrolled
13 charts
NCT03061812
2021-02-23
TAHOE
AbbVie
Phase 3
Completed
444 enrolled
16 charts